Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study

Styczynski, J.; Tridello, G.; Verheggen, I.; Knelange, N.; Wendel, L.; Ljungman, P.; Pinana, J. L.; Mikulska, M.; Gil, L.; Cesaro, S.; Ciceri, F.; Greco, R.; Wu, D.; Blaise, D.; Cerretti, R.; Chevallier, P.; Forcade, E.; Sicre De Fontbrune, F.; Mohty, M.; Ducastelle Lepretre, S.; Bulabois, C. E.; Nguyen Quoc, S.; Yakoub-Agha, I.; De La Camara, R.; Averbuch, D.

doi:10.1038/s41409-026-02898-x

Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study / Styczynski, J., Tridello, G., Verheggen, I., Knelange, N., Wendel, L., Ljungman, P., Pinana, J.L., Mikulska, M., Gil, L., Cesaro, S., Ciceri, F., Greco, R., Wu, D., Blaise, D., Cerretti, R., Chevallier, P., Forcade, E., Sicre De Fontbrune, F., Mohty, M., Ducastelle Lepretre, S., et al.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - 61:7(2026), pp. 941-943. [10.1038/s41409-026-02898-x]